iVexSol
Latest round
- Series A
Last raised
- Jan 2023
Total raised
- $39M
Investors
- 5
About iVexSol
iVexSol Inc.iVexSol Inc. was founded in 2019 and is headquartered in Worcester, US. The company develops technologies for vector production, particularly in the cell and gene therapy sectors., Ltd. and Bristol-Myers Squibb Company.iVexSol specializes in advanced vector production technologies, particularly for cell and gene therapies. Its core offerings include a next-generation stable lentiviral vector production platform and intelligent manufacturing solutions, aimed at overcoming challenges in lentiviral vector production. Utilizing serum-free, suspension host cells and engineered plasmids, iVexSol efficiently produces high-quality, high-titer vectors that support clients throughout clinical development stages, from preclinical trials to late-phase commercialization.iVexSol generates revenue through a B2B model, forming partnerships with biopharmaceutical companies and research institutions for vector production services. Revenue streams include contract agreements for on-demand vector production, where clients order based on their clinical development needs. Although specific pricing details are not disclosed, revenue is derived from both one-time production runs and ongoing support agreements.8 mn on January 26, 2023, iVexSol plans to enhance its technical teams and infrastructure to support the production of stable lentiviral vector producer cell lines. The company aims to expand its market presence, particularly targeting new geographical regions in Europe and Asia by late 2024, while continuing to innovate its product offerings to meet the increasing demand in the biopharmaceutical sector.
Who invested in iVexSol
5 investors across 3 rounds
See all investors in iVexSol
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about iVexSol
Who invested in iVexSol?
iVexSol has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iVexSol raised?
iVexSol has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did iVexSol last raise money?
iVexSol's most recent round on record is a Series A, in Jan 2023.
What does iVexSol do?
iVexSol is a biotechnology company.
Where is iVexSol headquartered?
iVexSol is headquartered in Worcester, US.
Which VCs invest in companies like iVexSol?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at iVexSol's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like iVexSol? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.